Study: Microdosing LSD for 1 month was followed by improved mood, productivity
Might microdosing LSD and psilocybin be a safe, effective way to treat depression and other disorders?
- A recent study collected the self-reports of more than 1,000 people who microdosed LSD or psilocybin regularly for about a month.
- The results showed that most people experienced more positive moods, less depression and increased productivity.
- These results are preliminary, and microdosing remains an under-researched area.
Microdosing psychedelic drugs on a regular basis might be a safe way to improve your mood and productivity, according to a new study published in the Journal of Psychoactive Drugs.
Microdosing is a practice in which you take a very small or "sub-perceptual" dose of drugs in order to reap the benefits of the drug without experiencing too much of its consciousness-altering effects. In the recent study, researchers collected reports from more than 1,000 participants in 59 countries, most of whom microdosed once every three days for a month. (The researchers defined microdoses as between 7 to 13 micrograms for LSD; 0.1 to 0.4 grams for dried psilocybin mushrooms.)
This microdosing regimen was followed by "improvements in negative moods, especially depression, and increases in positive moods. Increased energy, improved work effectiveness, and improved health habits were observed in clinical and nonclinical populations," the researchers wrote. One participant reported: "Feeling productive, able to focus on what I choose, enjoying relationships, good energy, and not recalling that I took anything."
The preliminary results suggest that "microdosing has none of the classic exciting effects of psychedelics, is safer, and many people all over the world report taking these low doses to be beneficial," study author James Fadiman, who's been researching psychedelics for decades, told PsyPost.
Still, the researchers cautioned against attaching clinical significance to their statistically significant results, which came from self-reports.
"While statistical significance can give us information about a low-level change over a large population — for example, improving one point on the Beck Depression Inventory — this may mean little to people suffering from depression," they wrote. "However, many participants informed us that they found microdosing to be an effective antidepressant, or replacement for their antidepressants. For example, a 70-year-old man writes: 'For the first time in 31 years, I am off antidepressants' and includes descriptions of moments when his emotional range has clearly been expanded."
The researchers also mentioned that the positive results could be explained by the placebo effect. That possibility didn't matter to at least one participant, who wrote: "I don't care if it's a placebo or not, all I know is I haven't felt this good in decades."
Other research on microdosing
Microdosing is far from a new idea. Decades ago, Albert Hoffman, the first scientist to synthesize and ingest LSD, suggested that low doses of LSD might be a suitable replacement for Ritalin. However, like psychedelics in general, scientists still have much to learn about how taking regular small doses of psychedelic drugs affects the body over time. Fortunately, there have been some illuminating studies and reports in recent years that suggest microdosing LSD or psilocybin has the potential to:
- Boost divergent and convergent thinking, both of which are considered fundamental to creativity. (Note: The 2018 study that observed these effects also found that microdosing seemed to have no effect on fluid intelligence.)
- Alleviate anxiety and depression.
- Increase productivity, at least as reported by many in Silicon Valley who've turned to microdosing as sort of the ultimate productivity hack.
Of course, if you're interested in microdosing or experimenting with psychedelic drugs, you should approach them at your own risk. After all, they're not for everybody, as Fadiman told PsyPost.
"People whose major symptom is anxiety should not microdose. Although there are thousands of years of recorded use, there are no contemporary double-blind studies. Inform yourself."
Upstreamism advocate Rishi Manchanda calls us to understand health not as a "personal responsibility" but a "common good."
- Upstreamism tasks health care professionals to combat unhealthy social and cultural influences that exist outside — or upstream — of medical facilities.
- Patients from low-income neighborhoods are most at risk of negative health impacts.
- Thankfully, health care professionals are not alone. Upstreamism is increasingly part of our cultural consciousness.
In most states, LGBTQ Americans have no legal protections against discrimination in the workplace.
- The Supreme Court will decide whether the Civil Rights Act of 1964 also applies to gay and transgender people.
- The court, which currently has a probable conservative majority, will likely decide on the cases in 2020.
- Only 21 states and the District of Columbia have passed laws effectively extending the Civil Rights of 1964 to gay and transgender people.
A new method promises to capture an elusive dark world particle.
- Scientists working on the Large Hadron Collider (LHC) devised a method for trapping dark matter particles.
- Dark matter is estimated to take up 26.8% of all matter in the Universe.
- The researchers will be able to try their approach in 2021, when the LHC goes back online.
No, depression is not just a type of "affluenza" — poor people in conflict zones are more likely candidates
- Often seen as typical of rich societies, depression is actually more prevalent in poor, conflict-ridden countries
- More than one in five Afghans is clinically depressed – a sad world record
- But are North Koreans really the world's 'fourth least depressed' people?
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.